By Josh White
Date: Monday 12 May 2025
(Sharecast News) - Tristel announced on Monday that it has received FDA clearance to begin immediate sales of its ophthalmic disinfectant foam, Tristel OPH, in the United States.
By Josh White
Date: Thursday 10 Apr 2025
(Sharecast News) - Tristel announced on Thursday that it has submitted the additional information requested by the US Food and Drug Administration for its Tristel OPH disinfectant, moving the product closer to potential FDA clearance, which it now expects by the end of June.
By Josh White
Date: Wednesday 09 Apr 2025
(Sharecast News) - Tristel reported growing traction for its 'Tristel ULT' disinfection foam in North America on Wednesday, underpinned by positive feedback from leading healthcare institutions and steady sales growth.
Currency | UK Pounds |
Share Price | 415.00p |
Change Today | 1.00p |
% Change | 0.24 % |
52 Week High | 500.00p |
52 Week Low | 270.00p |
Volume | 50,193 |
Shares Issued | 47.70m |
Market Cap | £197.96m |
RiskGrade | 180 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 20-Mar-25 | 28-Nov-24 |
Paid | 11-Apr-25 | 20-Dec-24 |
Amount | 5.68p | 8.28p |
Time | Volume / Share Price |
16:35 | 500 @ 415.00p |
16:35 | 1 @ 415.00p |
16:35 | 499 @ 415.00p |
15:31 | 7,000 @ 415.00p |
16:29 | 250 @ 421.00p |
Finance Director | Elizabeth Dixon |
CEO | Matthew (Matt) Giovanni Sassone |
You are here: research